chr5-13931231-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369.3(DNAH5):​c.71G>A​(p.Gly24Glu) variant causes a missense change. The variant allele was found at a frequency of 0.324 in 1,613,668 control chromosomes in the GnomAD database, including 92,045 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13455 hom., cov: 33)
Exomes 𝑓: 0.32 ( 78590 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 5.59

Publications

38 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.3286577E-6).
BP6
Variant 5-13931231-C-T is Benign according to our data. Variant chr5-13931231-C-T is described in ClinVar as Benign. ClinVar VariationId is 163159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH5NM_001369.3 linkc.71G>A p.Gly24Glu missense_variant Exon 2 of 79 ENST00000265104.5 NP_001360.1 Q8TE73

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkc.71G>A p.Gly24Glu missense_variant Exon 2 of 79 1 NM_001369.3 ENSP00000265104.4 Q8TE73

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
60659
AN:
151986
Hom.:
13436
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.571
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.698
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.284
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.297
Gnomad OTH
AF:
0.396
GnomAD2 exomes
AF:
0.367
AC:
92279
AN:
251192
AF XY:
0.358
show subpopulations
Gnomad AFR exome
AF:
0.576
Gnomad AMR exome
AF:
0.421
Gnomad ASJ exome
AF:
0.332
Gnomad EAS exome
AF:
0.695
Gnomad FIN exome
AF:
0.271
Gnomad NFE exome
AF:
0.293
Gnomad OTH exome
AF:
0.336
GnomAD4 exome
AF:
0.316
AC:
462539
AN:
1461564
Hom.:
78590
Cov.:
40
AF XY:
0.316
AC XY:
229815
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.580
AC:
19418
AN:
33462
American (AMR)
AF:
0.423
AC:
18902
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
8796
AN:
26124
East Asian (EAS)
AF:
0.694
AC:
27539
AN:
39686
South Asian (SAS)
AF:
0.357
AC:
30797
AN:
86256
European-Finnish (FIN)
AF:
0.276
AC:
14767
AN:
53410
Middle Eastern (MID)
AF:
0.320
AC:
1845
AN:
5766
European-Non Finnish (NFE)
AF:
0.288
AC:
320310
AN:
1111746
Other (OTH)
AF:
0.334
AC:
20165
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
16340
32680
49019
65359
81699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10954
21908
32862
43816
54770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.399
AC:
60722
AN:
152104
Hom.:
13455
Cov.:
33
AF XY:
0.398
AC XY:
29605
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.571
AC:
23703
AN:
41506
American (AMR)
AF:
0.393
AC:
5999
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
1200
AN:
3466
East Asian (EAS)
AF:
0.698
AC:
3615
AN:
5176
South Asian (SAS)
AF:
0.374
AC:
1806
AN:
4828
European-Finnish (FIN)
AF:
0.284
AC:
2999
AN:
10564
Middle Eastern (MID)
AF:
0.361
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
0.297
AC:
20211
AN:
67976
Other (OTH)
AF:
0.395
AC:
833
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1743
3486
5228
6971
8714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
31549
Bravo
AF:
0.415
TwinsUK
AF:
0.285
AC:
1056
ALSPAC
AF:
0.282
AC:
1085
ESP6500AA
AF:
0.563
AC:
2480
ESP6500EA
AF:
0.302
AC:
2599
ExAC
AF:
0.369
AC:
44816
Asia WGS
AF:
0.508
AC:
1764
AN:
3476
EpiCase
AF:
0.283
EpiControl
AF:
0.287

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly24Glu in exon 2 of DNAH5: This variant is not expected to have clinical signi ficance because it has been identified in 43.7% (1926/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs1530496). -

Primary ciliary dyskinesia Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 3 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
21
DANN
Benign
0.50
DEOGEN2
Benign
0.019
T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0000043
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-3.0
N
PhyloP100
5.6
PrimateAI
Benign
0.47
T
PROVEAN
Benign
4.0
N
REVEL
Benign
0.15
Sift
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.037
MPC
0.12
ClinPred
0.0094
T
GERP RS
5.6
Varity_R
0.14
gMVP
0.33
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1530496; hg19: chr5-13931340; COSMIC: COSV54209173; API